¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"residual schizophrenia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • pseudoneurotic schizophrenia
    °ÅÁþ½Å°æÁõÁ¤½ÅºÐ¿­º´
  • pseudopsychopathic schizophrenia
    °ÅÁþÁ¤½Åº´ÁõÁ¤½ÅºÐ¿­º´
  • paranoid schizophrenia
    ÆíÁýÁ¤½ÅºÐ¿­º´
  • paraphrenic schizophrenia
    ¸Á»óºÐ¿­Á¤½ÅºÐ¿­º´
  • schizophrenia
    Á¤½ÅºÐ¿­º´
  • schizophrenia simplex
    ´Ü¼øÁ¤½ÅºÐ¿­º´
  • simple type schizophrenia
    ´Ü¼øÇüÁ¤½ÅºÐ¿­º´
  • undifferentiated schizophrenia
    ¹ÌºÐ·ùÁ¤½ÅºÐ¿­º´
  • functional residual air
    ±â´ÉÀûÀܱâ
  • functional residual capacity
    ±â´ÉÀܱâ¿ë·®
  • residual
    1. ÀÜ·ù- 2. ÀÜ¿©-, ÀÜÁ¸- 3. ÈÄÀ¯-
  • residual abscess
    ÀÜ·ù°í¸§Áý, ÀÜ·ù³ó¾ç
  • residual accommodation
    ÀÜ¿©Á¶Àý
  • residual antigen
    ÀÜ·ùÇ׿ø
  • residual astigmatism
    ÀÜÁ¸³­½Ã
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • latent schizophrenia
    ÀáÀçÁ¤½ÅºÐ¿­º´
  • negative schizophrenia
    À½¼ºÁ¤½ÅºÐ¿­º´
  • paranoid schizophrenia
    ÆíÁýÁ¤½ÅºÐ¿­º´
  • paraphrenic schizophrenia
    ¸Á»óºÐ¿­Á¤½ÅºÐ¿­º´
  • positive schizophrenia
    ¾ç¼ºÁ¤½ÅºÐ¿­º´
  • prepsychotic schizophrenia
    Á¤½Åº´ÀüÁ¤½ÅºÐ¿­º´
  • process schizophrenia
    ÁøÇàÁ¤½ÅºÐ¿­º´
  • prodromal schizophrenia
    Àü±¸´Ü°èÁ¤½ÅºÐ¿­º´
  • propf schizophrenia
    À̽ÄÁ¤½ÅºÐ¿­º´
  • pseudoneurotic schizophrenia
    °ÅÁþ½Å°æÁõÁ¤½ÅºÐ¿­º´
  • pseudopsychopathic schizophrenia
    °ÅÁþÁ¤½Åº´ÁõÁ¤½ÅºÐ¿­º´
  • schizophrenia
    Á¤½ÅºÐ¿­º´
  • schizophrenia simplex
    (¢¡simple type schizophrenia) ´Ü¼øÁ¤½ÅºÐ¿­º´
  • simple type schizophrenia
    ´Ü¼øÁ¤½ÅºÐ¿­º´
  • undifferentiated schizophrenia
    ¹ÌºÐ·ùÁ¤½ÅºÐ¿­º´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • schizophrenia, ambulatory
    Ȱµ¿Çü Á¤½ÅºÐ¿­º´
  • schizophrenia, atypical
    ºñÁ¤Çü¼º Á¤½ÅºÐ¿­º´
  • schizophrenia, catalepsy
    °­°æÁõÇü Á¤½ÅºÐ¿­º´
  • schizophrenia, catatonic
    ±äÀåÇü Á¤½ÅºÐ¿­º´
  • schizophrenia, cenesthopathic
    ü°¨Àå¾ÖÇü Á¤½ÅºÐ¿­º´
  • schizophrenia, childhood onset
    ¾Æµ¿±â¹ßº´ Á¤½ÅºÐ¿­º´
  • schizophrenia, cyclic
    ¼øÈ¯Çü Á¤½ÅºÐ¿­º´
  • schizophrenia, disorganized type
    ºØ±«Çü Á¤½ÅºÐ¿­º´
  • schizophrenia, flexibilitas cerea
    ³³±¼ÁõÇü Á¤½ÅºÐ¿­º´
  • schizophrenia, hebephrenic type
    ÆÄ°úÇü Á¤½ÅºÐ¿­º´
  • schizophrenia, late-onset
    Èıâ¹ßº´ Á¤½ÅºÐ¿­º´
  • schizophrenia, latent
    ÀáÀçÇü Á¤½ÅºÐ¿­º´
  • schizophrenia, negative
    À½¼º Á¤½ÅºÐ¿­º´
  • schizophrenia, paranoid type
    ÆíÁýÇü Àü½ÅºÐ¿­º´
  • schizophrenia, paraphrenic
    ¸Á»óºÐ¿­Çü Á¤½ÅºÐ¿­º´
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SADS Schedule for Affective Disorders and Schizophrenia
SADS-C Schedule for Affective Disorders and Schizophrenia-Change
SADS-L Schedule for Affective Disorders and Schizophrenia-Lifetime
schiz schizophrenia
SFH schizophrenia family history; serum-free hemoglobin; stroma-free hemoglobin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SCH schizophrenia
SCZ schizophrenia
SZ schizophrenia
FRC Functional Residual Capacity
VmaxFRC Maximal flow at functional residual capacity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • residual body
    ÀÜ¿©Ã¼
    Plasmodium¿¡¼­¿Í °°ÀÌ »ý½Ä ºÐ¿­À» ¿Ï·áÇÑ ÈÄ ³²¾ÆÀÖ´Â ¿øÇüÁú µ¢¾î¸®.
  • residual bone
    ÀÜÁ¸°ñ
  • residual cyst
    ÀÜ·ù ³¶, ÀÜ·ù¼º ³­Á¾
    1. ´ë°³ Ä¡±Ù´Ü ³¶Á¾À¸·Î ÇØ´ç Ä¡¾ÆÀÇ ¹ßÄ¡ ÈÄ¿¡µµ ±× ÀÚ¸®¿¡ ³²¾Æ¼­ ¹ß»ýÇÑ´Ù. ¹æ»ç¼± »çÁø»ó º´¼Ò´Â °æ°è°¡ ¸íÈ®ÇÑ ±ÕÁúÇÑ ´Ü¹æ¼º ¾Ï¿°À» ³ªÅ¸³½´Ù. 2. ´ë°³ Ä¡±Ù´Ü ³¶Á¾À¸·Î ÇØ´ç Ä¡¾ÆÀÇ ¹ß°Å ÈÄ¿¡µµ ±× À§Ä¡¿¡ ³²¾Æ¼­ ¹ß»ýÇÑ´Ù. ÀÜ·ù¼º, Ãø¹æ Ä¡ÁÖ¼º ¹× ÇÔÄ¡¼º ³¶Á¾ µîÀº »óÈ£ ºñ½ÁÇÏ¿© °¨º°ÀÌ Èûµé ¶§°¡ Àֱ⠶§¹®¿¡ ¹ßÄ¡Àü ¹æ»ç¼± »çÁøÀ» Âü°íÇØ¾ß ÇÏ¸ç ¾Ç°ñÀÇ ¹«Ä¡¾Ç ºÎÀ§¿¡ ¹ß»ýÇÏ´Â ¿ø½Ã¼º ³¶Á¾µµ ¼úÀü ±â·Ï°ú º´·ÂÀ¸·Î °¨º°ÇÑ´Ù. ¹æ»ç¼± »çÁø»ó, º´¼Ò´Â °æ°è°¡ ¸íÈ®ÇÑ ±ÕÁúÇÑ ´Ü¹æ¼º ¾Ï¿µÀ» ³ªÅ¸³½´Ù. ¿Í°úÀû ÀýÃâ°ú ¼ÒÆÄ¼ú·Î Ä¡·áÇÑ´Ù.
  • residual dental caries
    ÀÜÁ¸ Ä¡¾Æ¿ì½ÄÁõ
    ÀÜÁ¸ Ä¡¾Æ ¿ì½Ä »ó¾ÆÁú. ¿ì½ÄÀÌ µÈ ¹°ÁúÀÌ »èÁ¦µÈ ¿Íµ¿¿¡ ³²¾Æ ÀÖ°í ±× À§¿¡ ÃæÀü¹°ÀÌ À§Ä¡ÇÑ °Í.
  • residual mercury
    ÀÜ¿© ¼öÀº
  • residual pulp
    Àܼö
  • residual ridge crest
    ÀÜÁ¸ Ä¡Á¶´É
  • residual root
    ÀܱÙ
  • residual shrinkage
    ÀÜ·ù À§Ãà
  • residual stress
    ÀÜ·ù ÀÀ·Â, ÀÜ¿© ÀÀ·Â
    Àη¹ÀÌ ³³Çü Á¦ÀÛ ½Ã ³³ °¡¿­ÀÌ ºÎÁ·ÇϹǷΠÀÎÇØ Àη¹ÀÌ ¿Íµ¿¿¡ ¾ïÁö·Î ¾ÐÀÔÇÏ°Ô µÇ´Âµ¥ À̶§ ¾Ð·ÂÀ» ¸¹ÀÌ ¹ÞÀº ºÎºÐ¿¡ Àû°Ô ¹ÞÀº ºÎºÐº¸´Ù ÀÜÀ¯ ÀÀ·ÂÀÌ Á¸ÀçÇÔÀ¸·Î¼­ ³³ÇüÀÇ º¯ÇüÀ» ÃÊ·¡ÇÒ ¼ö°¡ ÀÖ´Ù.
  • residual urine
    ÀÜ´¢
  • schizophrenia of childhood type
    ¾Æµ¿Çü Á¤½Å ºÐ¿­Áõ
    »çÃá±â¿¡ ¹ßº´ÇÏ´Â Á¤½Å ºÐ¿­ÁõÀ¸·Î¼­ ÀÚÆó¼º, ³»Ç⼺, ºñÁ¤ÇüÀû ÇൿÀ» Ư¡À¸·Î ÇÑ´Ù.
  • simple schizophrenia
    ´Ü¼ø Á¤½Å ºÐ¿­º´
    Á¤½Å ºÐ¿­º´ÀÌ ¼­¼­È÷ ÀáÇ༺À¸·Î ÁøÇàµÇ´Â º´ÇüÀ¸·Î¼­, ¹«°¨µ¿, ¹ßµ¿¼º °á¿©, ¹«°ü½É ¹× ³»Æó¼ºÀ» Ư¡À¸·Î ÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
psychosis, schizophrenia The most chronic and disabling of the major mental illnesses. Schizophrenia may be one disorder, or it may be many disorders, with different causes. Because of the disorder's complexity, few generalisations hold true for all people who are diagnosed as schizophrenic.
(12 Dec 1998)
simple schizophrenia Schizophrenia characterised by withdrawal, apathy, indifference, and impoverishment of human relationships without overt psychotic features.
(05 Mar 2000)
disorganised schizophrenia A severe form of schizophrenia characterised by the predominance of incoherence, blunted, inappropriate or silly affect, and the absence of systematised delusions.
Synonym: hebephrenic schizophrenia.
(05 Mar 2000)
latent schizophrenia A preexisting susceptibility for developing overt schizophrenia under strong emotional stress.
(05 Mar 2000)
residual Remaining or left behind.
Origin: L. Residuus
(18 Nov 1997)
residual abscess An abscess recurring at the site of a former abscess resulting from persistence of microbes and pus.
(05 Mar 2000)
residual affinity Secondary forces that enable apparently saturated atoms, ions, or molecules to attract other atoms or groups, causing such phenomena as complex formation, hydration, adsorption, etc.
(05 Mar 2000)
residual air The volume of air remaining in the lungs at the end of a maximal expiration. Common abbreviation is rv.
(12 Dec 1998)
residual body 1. <cell biology> Secondary lysosomes containing material that cannot be digested.
2. <biology> The surplus cytoplasm shed by spermatids during their differentiation to spermatozoa. Usually the cytoplasm from several spermatids connected by cytoplasmic bridges.
3. <microbiology> Surplus cytoplasm containing pigment and left over after production of merozoites during schizogony of malaria parasites.
(18 Nov 1997)
residual body of Regaud The excess cytoplasm that separates from the spermatozoon during spermiogenesis.
(05 Mar 2000)
residual capacity The volume of air remaining in the lungs at the end of a maximal expiration. Common abbreviation is rv.
(12 Dec 1998)
residual cleft The remnants of the pituitary diverticulum that occur between the pars distalis and pars intermedia; a distinct lumen is present in some animals, but, in humans, is present only during prenatal development and sometimes in young children.
Synonym: residual lumen.
(05 Mar 2000)
residual cyst The persistence of an apical periodontal cyst that remains after tooth extraction.
(05 Mar 2000)
residual error The estimated discrepancy between the actual measured datum and the value for that value computed after a model has been fitted to the set of the data by an estimator.
(05 Mar 2000)
residual inhibition The inhibition or suppression of tinnitus by use of a sound-generating device (residual inhibitor) which masks the sounds of tinnitus and produces a residual sound-inhibiting effect when the device is turned off.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á